Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Automated Point-of-Care Nerve Conduction Tests | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Automated Percutaneous and Percutaneous Endoscopic Discectomy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Automated Insulin Delivery Systems | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Autologous Hematopoietic Stem-Cell Transplantation for Malignant Astrocytomas and Gliomas | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Augmentation Mammoplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Auditory Brainstem Implant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Atypical Antipsychotics | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Atopic Dermatitis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis and Predict Therapeutic Response in Individuals With Breast Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Aspirin Resistance Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Artificial Intervertebral Disc: Lumbar Spine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Artificial Intervertebral Disc: Cervical Spine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Arthroscopic Debridement and Lavage as Treatment of Osteoarthritis of the Knee | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Aqueous Shunts and Stents for Glaucoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Apomorphine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Antigen Testing for Rapid Detection of Coronavirus Disease 2019 (COVID-19) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Antigen Leukocyte Antibody Test (ALCAT) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Antibody Tests for Neurologic Diseases | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Anti-Rheumatic Biologicals | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Anti-CCP Testing for Rheumatoid Arthritis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Analysis of Proteomic Patterns for Early Detection of Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Analysis of MGMT Promoter Methylation in Malignant Gliomas | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Amtagvi (lifileucel) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Amniotic Membrane and Amniotic Fluid | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ambulance and Medical Transport Services | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Alpha-1 Proteinase Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allograft Injection for Degenerative Disc Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allogeneic Pancreas Transplant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allergy Tests of Uncertain Efficacy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allergy Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allergy Immunotherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Albendazole | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Akynzeo (netupitant and palonosetron) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Agents for Recurrent Clostridioides Difficile | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adoptive Immunotherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adjunctive Techniques for Screening, Surveillance, and Risk Classification of Barrett Esophagus and Esophageal Dysplasia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adakveo (crizanlizumab-tmca) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Acute and Maintenance Tocolysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Actimmune (interferon gamma-1b) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Actigraphy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | ACTH Gel (Repository Corticotropin Injection) | New policy |